公司资料
Nutriband 股价、新闻与催化剂
- 股票代码:
- NTRB
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
3.23 USD (-2.12%)
收盘价
最后更新: 2026年8月17日
43.2M USD
市值
股价为何变动
As of Aug 17, 2026, NTRB closed down 2.12% at $3.23. No new same-company headline was identified in the current news window.
公司概览
业务概览
Nutriband is a specialty drug-delivery company focused on transdermal technologies and abuse-deterrent patch platforms. Its story is centered on formulation science and the possibility of licensing or commercializing delivery systems for regulated products.
所在地与行业分类
Nutriband is headquartered in the United States and listed on NASDAQ, with a small-cap specialty drug-delivery profile. It sits in the pharmaceutical technology niche rather than broad biotech.
商业模式特征
The business depends on product development, regulatory progress, and partner interest in the delivery platform. Investors typically watch licensing, formulation updates, and the company's ability to create value from a narrow technology base.
生物医药行业定位
Nutriband occupies a niche position in drug delivery and abuse-deterrent formulation. It is more of a platform story than a classic therapeutics stock.
未来催化剂
- Nutriband’s catalysts are Aversa-related transdermal abuse-deterrent development and any regulatory step that keeps the platform credible. The company still needs a practical commercialization path.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。